Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Beginning Cash Balance (2016 - 2025)

Historic Beginning Cash Balance for China Pharma Holdings (CPHI) over the last 12 years, with Q4 2022 value amounting to -$4026.0.

  • China Pharma Holdings' Beginning Cash Balance fell 10129.54% to -$4026.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $223013.0, marking a year-over-year decrease of 6036.44%. This contributed to the annual value of $223013.0 for FY2022, which is 6036.44% down from last year.
  • As of Q4 2022, China Pharma Holdings' Beginning Cash Balance stood at -$4026.0, which was down 10129.54% from -$4317.0 recorded in Q3 2022.
  • China Pharma Holdings' 5-year Beginning Cash Balance high stood at $310783.0 for Q4 2021, and its period low was -$4850.0 during Q2 2022.
  • Moreover, its 4-year median value for Beginning Cash Balance was $111691.0 (2019), whereas its average is $102821.2.
  • In the last 5 years, China Pharma Holdings' Beginning Cash Balance soared by 17235.63% in 2021 and then crashed by 2888000.0% in 2022.
  • Quarter analysis of 4 years shows China Pharma Holdings' Beginning Cash Balance stood at $111691.0 in 2019, then increased by 2.16% to $114109.0 in 2020, then surged by 172.36% to $310783.0 in 2021, then tumbled by 101.3% to -$4026.0 in 2022.
  • Its Beginning Cash Balance was -$4026.0 in Q4 2022, compared to -$4317.0 in Q3 2022 and -$4850.0 in Q2 2022.